Skip to main content
. Author manuscript; available in PMC: 2015 May 25.
Published in final edited form as: Mol Cell Endocrinol. 2014 Jan 22;389(0):2–6. doi: 10.1016/j.mce.2014.01.013

Figure 2. Bridging the Gap.

Figure 2

These four crucial areas need to be addressed by both scientists and clinicians in order to optimize postmenopausal ET and better protect the neurological health of prematurely menopausal women. E2, 17β-Estradiol; ET, Estrogen Therapy; RCT, Randomized Controlled Clinical Trials.